|
|
Home
> CSL Behring -- Biotherapies for Life
CSL Behring is committed to saving lives and improving the quality of life for people with rare and serious diseases worldwide.
4 March 2010Hizentra™ Receives U.S. FDA Approval
1 March 2010HAE Data Presented at AAAAI
1 March 201020% Subcutaneous Ig Data Presented at AAAAI
4 February 2010Biostate Clinical Program, SWIFT, Launches in Europe
|